Objectives: To identify barriers, facilitators, and strategies for future implementation of the OMERACT-Adherence Core Outcome Set (COS) in medication adherence trials for rheumatic conditions.
Methods: Preliminary Delphi survey findings were discussed at OMERACT 2023, utilising the Consolidated Framework for Implementation Research 2 to identify implementation barriers, facilitators, and solutions.
Results: Implementation strategies included simplifying the COS definitions, making it adaptabile for clinical practice and drug trials, adherence trial training workshops, and collaborating with key stakeholders such as payers and other COS developers.
Conclusion: Ongoing collaboration with individuals and organisations within and beyond rheumatology ensures broader applicability of OMERACT-Adherence COS.
To identify barriers, facilitators, and strategies for future implementation of the OMERACT-Adherence Core Outcome Set (COS) in medication adherence trials for rheumatic conditions.
ContributorsAria Mohammadi Kordkheili, Charlotte Bekker, Alison M Hoens, Marieke Voshaar, Willemina Campbell, Loreto Carmona, Maarten de Wit, Lyn March, Sabrina Mai Nielsen, Beverley J Shea, Karine Toupin-April, Peter Tugwell, Kathleen Tymms, Ayano Kelly
Disease Category: Rheumatology
Disease Name:
Age Range: Unknown
Sex:
Nature of Intervention:
- COS methods research